Public relations and planning documents from AstraZeneca discuss promoting "off-label" or unapproved uses for the company's drug Seroquel. The U.S. Food and Drug Administration has approved Seroquel for schizophrenia, psychotic and bipolar disorders among adults.

There's a "crazy quilt of about 140 businesses and organizations that jumped into the climate change debate on Capitol Hill in the first quarter of this year," reports Marianne Lavelle.

A class-action lawsuit charging major tobacco companies and a public relations firm with a "decades-long campaign of deceptive advertising and misleading statements" can proceed, ruled the California Supreme Court.